Organic compounds -- part of the class 532-570 series – Organic compounds – Fatty compounds having an acid moiety which contains the...
Reexamination Certificate
2011-08-09
2011-08-09
Sullivan, Daniel (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Fatty compounds having an acid moiety which contains the...
C554S035000, C514S563000
Reexamination Certificate
active
07994353
ABSTRACT:
The present invention provides PPAR (peroxisome proliferator-activated receptor) activity regulators, which can be widely used for improving insulin resistance and preventing/treating various diseases such as diabetes, metabolic syndromes, hyperlipemia, high-blood pressure, vascular disorders, inflammation, hepatitis, fatty liver, liver fibrosis, NASH (non-alcoholic steatohepatitis) and obesity.
REFERENCES:
patent: 6090250 (2000-07-01), Mazzeo et al.
patent: 2006/0014820 (2006-01-01), Burstein et al.
patent: 2007/0276041 (2007-11-01), Oonuki et al.
patent: 2007/0282002 (2007-12-01), Maezono et al.
U.S. Appl. No. 12/621,142, filed Nov. 18, 2009, Maezono, et al.
Evan, R. M., et al., “PPARs and the Complex Journey to Obesity,” Nature Medicine, vol. 10, No. 4, Apr. 2004, pp. 1-7.
Henke, B. R., “Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes,” J. Med. Chem., 47, 2004, pp. 4118-4127.
Skrumsager, B. K., et al., “Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPAR α and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes,” J. Clin. Pharmacol., 43, 2003, pp. 1244-1256.
http://en.wikipedia.org/wiki/Prodrug (2 pages), Aug. 28, 2008.
Han et al., Targeted Prodrug Design to Optimize Druge Delivery, 2000, AAPS pharmsci, vol. 2, (1), article 6, pp. 1-11.
http://en/ikipedia.org./siki/Levopoda (5 pages), Aug. 28, 2008.
Fukuchi Naoyuki
Ishida Nozomu
Kawato Yayoi
Maezono Katsumi
Oonuki Akiko
Ajinomoto Co. Inc.
Cutliff Yate K
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Sullivan Daniel
LandOfFree
PPAR activity regulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PPAR activity regulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PPAR activity regulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2638449